Relationship between SLCO1B1 polymorphisms and methotrexate intolerance in Mexican children with juvenile idiopathic arthritis
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07221-x ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Jimena Garcia-Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Pediatría, Hospital Universitario "José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero Pte. y Av. G…. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Methotrexate, Liver-Specific Organic Anion Transporter 1, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
INTRODUCTION: The most frequent adverse events (AEs) of methotrexate (MTX) are gastrointestinal symptoms and hepatotoxicity, which can affect its adherence, leading to reduced effectiveness. The SLCO1B1 gene codes for a liver protein (OATP1B1) responsible for drug transportation. Genetic variations within the SLCO1B1 gene locus impact drug transport, leading to altered pharmacokinetic profiles, delayed MTX clearance, and increased risk of toxicity. This study aimed to determine the association between single nucleotide polymorphisms (SNPs) in the SLCO1B1 gene (rs4149056, rs2306283) with the development of AEs in patients with juvenile idiopathic arthritis (JIA) treated with MTX. METHOD: We performed an observational retrospective study to analyze the relationship between SNPs in the SLCO1B1 gene and the development of AEs in pediatric patients treated with MTX for JIA. RESULTS: Thirty patients with JIA were included, 22 females (73.3%), with a median age of 11 years (IQR 8.3-15). The most frequent JIA subtype was rheumatoid factor-positive polyarthritis (36.7%). Twenty patients (66.7%) reported AEs. The *1B haplotype was the most frequent in this group (53.3%) and conferred a higher risk of developing AEs (OR = 3.89, 95% CI = 1.23 -12.29, p = 0.03). CONCLUSIONS: Patients with the allele *1B may benefit from lower doses of MTX. SLCO1B1 genotyping is a promising technique to identify patients at higher risk of AEs during treatment with MTX, thus requiring dose optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Pediatría, Hospital Universitario "José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero Pte. y Av. Gonzalitos, Col. Mitras Centro C.P., 64460, Monterrey, NL, Mexico.
- Departamento de Inmunogenetica, Centro de Investigación Biomédica del Noreste, Instituto Mexicano del Seguro Social, Monterrey, Mexico.
- Departamento de Pediatría, Hospital Universitario "José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero Pte. y Av. Gonzalitos, Col. Mitras Centro C.P., 64460, Monterrey, NL, Mexico. fern…
Zitieren
APA
Garcia-Silva, J., Silva-Ramirez, B., Villarreal-Treviño, A. V., Mata-Tijerina, V., Rubio-Perez, N. E., & Garcia-Rodriguez, F. (2024). Relationship between SLCO1B1 polymorphisms and methotrexate intolerance in Mexican children with juvenile idiopathic arthritis. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07221-x
Vancouver
Garcia-Silva J, Silva-Ramirez B, Villarreal-Treviño AV, Mata-Tijerina V, Rubio-Perez NE, Garcia-Rodriguez F. Relationship between SLCO1B1 polymorphisms and methotrexate intolerance in Mexican children with juvenile idiopathic arthritis. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07221-x
BibTeX
@article{GarciaSilva2024,
author = {Garcia-Silva, Jimena and Silva-Ramirez, Beatriz and Villarreal-Treviño, Ana V and Mata-Tijerina, Viviana and Rubio-Perez, Nadina E and Garcia-Rodriguez, Fernando},
title = {Relationship between SLCO1B1 polymorphisms and methotrexate intolerance in Mexican children with juvenile idiopathic arthritis},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07221-x}
}
EUVIMED